BRPI0416731A - métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor - Google Patents

métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor

Info

Publication number
BRPI0416731A
BRPI0416731A BRPI0416731-7A BRPI0416731A BRPI0416731A BR PI0416731 A BRPI0416731 A BR PI0416731A BR PI0416731 A BRPI0416731 A BR PI0416731A BR PI0416731 A BRPI0416731 A BR PI0416731A
Authority
BR
Brazil
Prior art keywords
pet
tract
amount
reducing
desulfovibrio
Prior art date
Application number
BRPI0416731-7A
Other languages
English (en)
Inventor
Christina Khoo
Kathy Lynn Gross
Glenn Gibson
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of BRPI0416731A publication Critical patent/BRPI0416731A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"MéTODOS PARA A REDUçãO DA QUANTIDADE DE DESULFOVIBRIO E/OU HELICOBACTER SPP. NO TRATO GI DE UM ANIMAL DE ESTIMAçãO, PARA TRATAMENTO DE UMA INFLAMAçãO DO TRATO GI EM UM ANIMAL DE ESTIMAçãO, E PARA A REDUçãO DE UM ODOR". Método para a redução da quantidade de ~Desulfovibrio e/ou Helicobacter spp. no trato GI de um animal de estimação de companhia, que compreende a administração oral no referido animal de estimação de uma quantidade de uma fibra ou de outro componente de redução de Desulfovibrio e/ou Helicobacter spp.
BRPI0416731-7A 2003-11-21 2004-11-19 métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor BRPI0416731A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/719,569 US6936598B2 (en) 2003-11-21 2003-11-21 Composition and method
PCT/US2004/038697 WO2005051403A1 (en) 2003-11-21 2004-11-19 Composition and method

Publications (1)

Publication Number Publication Date
BRPI0416731A true BRPI0416731A (pt) 2007-01-16

Family

ID=34591365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416731-7A BRPI0416731A (pt) 2003-11-21 2004-11-19 métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor

Country Status (12)

Country Link
US (1) US6936598B2 (pt)
EP (2) EP1684771B1 (pt)
JP (1) JP4802103B2 (pt)
CN (1) CN100479827C (pt)
AU (1) AU2004292973B2 (pt)
BR (1) BRPI0416731A (pt)
CA (1) CA2545572C (pt)
DK (1) DK1684771T3 (pt)
ES (1) ES2604454T3 (pt)
RU (1) RU2375065C2 (pt)
WO (1) WO2005051403A1 (pt)
ZA (1) ZA200604070B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2563372A4 (en) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc PREBIOTIC FORMULATIONS AND METHODS OF USE
US20130287919A1 (en) * 2012-04-26 2013-10-31 Flavitpure, Inc. Method of using dietary ingredients dihydroquercetin (taxifolin), arabinogalactan and arabinogalactan in combination with dihydroquercetin (taxifolin) for applications in food products
US20130331354A1 (en) * 2012-06-07 2013-12-12 Flavitpure, Inc. Method and composition utilizing larch wood extracts in animal feed
US9145340B2 (en) 2012-08-13 2015-09-29 Verdesian Life Sciences, Llc Method of reducing atmospheric ammonia in livestock and poultry containment facilities
US9961922B2 (en) * 2012-10-15 2018-05-08 Verdesian Life Sciences, Llc Animal feed and/or water amendments for lowering ammonia concentrations in animal excrement
US11254620B2 (en) 2013-08-05 2022-02-22 Verdesian Life Sciences U.S., Llc Micronutrient-enhanced polymeric seed coatings
TW201522390A (zh) 2013-08-27 2015-06-16 特級肥料產品公司 聚陰離子聚合物
WO2015035031A1 (en) 2013-09-05 2015-03-12 Verdesian Life Sciences, Llc Polymer-boric acid compositions
CA2945823C (en) 2014-05-21 2022-04-26 Verdesian Life Sciences, Llc Polymer soil treatment compositions including humic acids
WO2015179552A1 (en) 2014-05-22 2015-11-26 Verdesian Life Sciences, Llc Polymeric compositions
MX382329B (es) * 2015-12-30 2025-03-13 Hills Pet Nutrition Inc Composiciones de alimento para mascotas.
CN105943463B (zh) * 2016-06-23 2019-03-15 金日制药（中国）有限公司 一种温和的婴童洗发沐浴泡泡
US10842809B2 (en) 2016-12-16 2020-11-24 Hills Pet Nutrition, Inc. Pet food compositions
US11260099B2 (en) 2016-12-16 2022-03-01 Hills Pet Nutrition, Inc. Pet food compositions

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2549638B2 (ja) * 1986-10-30 1996-10-30 サントリー株式会社 ビフイズス菌増殖促進組成物
JP2901805B2 (ja) * 1991-05-31 1999-06-07 マルハ株式会社 ペットフード
US5294458A (en) * 1992-04-03 1994-03-15 Maruha Corporation Pet food
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
RU2105548C1 (ru) * 1994-06-24 1998-02-27 Владимир Дмитриевич Соколов Препарат "диарин" для лечения и профилактики желудочно-кишечных болезней молодняка животных
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
FR2756181B1 (fr) * 1996-11-26 1999-03-05 Au Mont Beaute Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
US5952033A (en) * 1996-12-24 1999-09-14 Nestec S.A. Gelatinized cereal product containing oligosaccharide and processes of preparing and using same
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
PT1003532E (pt) * 1997-07-05 2002-04-29 Nestle Sa Lactobacilos para aumentar a absorcao de minerais pelas celulas do intestino
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
GB9905542D0 (en) * 1999-03-10 1999-05-05 Mars Uk Ltd Pet food
IT1307850B1 (it) * 1999-03-15 2001-11-19 Italmed Di Galli Giovanna E Pa Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US6468525B1 (en) * 1999-08-10 2002-10-22 Renew Life, Inc. Probiotic formulation
DE10021384A1 (de) * 2000-05-03 2001-11-15 Hora Reiner Ergänzungsfutter für Haustiere
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
FR2815823B1 (fr) * 2000-10-31 2005-04-22 Colloides Naturels Internat Methode et preparation de type fibre alimentaire soluble bifidogene pour la mise en oeuvre de ladite methode
GB0027824D0 (en) * 2000-11-15 2000-12-27 Lattice Intellectual Property Bacterial control
US20040044988A1 (en) * 2002-08-29 2004-03-04 Schene Christopher Robin Generation of compiled code for simulator speed up

Also Published As

Publication number Publication date
EP1684771A1 (en) 2006-08-02
WO2005051403A1 (en) 2005-06-09
CN100479827C (zh) 2009-04-22
RU2375065C2 (ru) 2009-12-10
JP4802103B2 (ja) 2011-10-26
CA2545572A1 (en) 2005-06-09
CA2545572C (en) 2015-02-10
ES2604454T3 (es) 2017-03-07
AU2004292973A1 (en) 2005-06-09
AU2004292973B2 (en) 2010-11-25
EP1684771B1 (en) 2016-08-24
JP2007512342A (ja) 2007-05-17
RU2006121995A (ru) 2007-12-27
ZA200604070B (en) 2007-09-26
US6936598B2 (en) 2005-08-30
CN1882351A (zh) 2006-12-20
DK1684771T3 (en) 2016-11-28
US20050113334A1 (en) 2005-05-26
EP3111943A1 (en) 2017-01-04
EP1684771A4 (en) 2010-07-14
EP3111943B1 (en) 2019-06-12

Similar Documents

Publication Publication Date Title
BRPI0416731A (pt) métodos para a redução de quantidade de desulfovibrio e/ou helicobacter spp. no trato gi de um animal de estimação, para tratamento de uma inflamação do trato gi em um animal de estimação, e para a redução de um odor
AR064363A1 (es) Tratamiento de cerdos con el antigeno pcv
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
AR049955A1 (es) Composiciones y metodos para el tratamiento de trastornos metabolicos
WO2007005716A3 (en) Methods of treatment and compositions for use thereof
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
BR0214962A (pt) Composição para tratar distúrbios neurocerebrovasculares
BRPI0502346A (pt) processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica
WO2007133840A3 (en) Treatment device and method for treating or preventing periodontal disease through application of heat
BRPI0507279A (pt) método e dispositivo para o tratamento do canal da teta de um animal
ZA200904461B (en) Non-specific immunostimulating agents
EA201000855A1 (ru) Способ и средства для достижения бронхиальной релаксации
EA201100413A1 (ru) Способ лечения бактериальной инфекции
WO2011028794A3 (en) Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida
BRPI0906049A2 (pt) "método para determinar se um câncer um paciente é resistente ao tratamento com um agente antimitótico, método para tratar um paciente com câncer que é resistente ao gente antimitótico e método de tratamento"
MX2009003912A (es) Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas.
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BRPI0413083A (pt) métodos para tratar inflamação e doenças associadas com inflamação com uma estatina e éter
EP1441708A4 (en) COMPOSITIONS AND METHODS FOR INCREASING THE COMPLIANCE WITH THERAPIES USING ALDEHYDEDEHYDROGENASE INHIBITORS AND TREATING ALCOHOL MUSIC
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
BR0312591A (pt) Efeito sinérgico da dieta e da interação com ser humano sobre o comportamento de cães
BRPI0519036A2 (pt) mÉtodo para o tratamento de um paciente acometido por uma doenÇa neuro-degenerativa; composiÇço farmacÊutica para tratar uma doenÇa neuro-degenerativa; e uso de um agonista 5-ht6 ou de um agonista 5-ht6
WO2006138385A3 (en) Use of phenserine and analogs to treat behavioral problems and improve trainability
WO2006136428A3 (en) Method and composition to treat skin ulcers

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 31/715, 31/716; A23K 1/00; A61P 1/04, 31/04

Ipc: A61K 31/715 (2011.01), A61K 31/716 (2011.01), A23K

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/702 (2006.01), A23K 20/111 (2016.01), A23K